Overview
Patrick Beatty is a Hematologist Oncology provider in Missoula, Montana. Dr. Beatty is highly rated in 2 conditions, according to our data. His top areas of expertise are Reticuloendotheliosis, Hairy Cell Leukemia (HCL), Non-Hodgkin Lymphoma, and Carcinoid Syndrome.
His clinical research consists of co-authoring 5 peer reviewed articles. MediFind looks at clinical research from the past 15 years.
Specialties
Licenses
Languages Spoken
Gender
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- OTHER MEDICAID
- STATE MEDICAID
- EPO
- HMO
- POS
- PPO
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Karl Sorenson is a Hematologist Oncology provider in Missoula, Montana. Dr. Sorenson is highly rated in 3 conditions, according to our data. His top areas of expertise are Paget Disease of the Breast, Muscle Invasive Bladder Cancer, Breast Cancer, and Neuroendocrine Tumor. Dr. Sorenson is currently accepting new patients.
Frequently Asked Questions about Dr. Patrick G. Beatty
How do I make an appointment with Dr. Patrick G. Beatty?
You can book an appointment with Dr. Patrick G. Beatty by calling their office at 406-728-2539. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.
Is Dr. Patrick G. Beatty a top-rated expert for Reticuloendotheliosis?
MediFind is an objective health platform that identifies experts based on real-world data. Dr. Patrick G. Beatty is classified as an Advanced expert for Reticuloendotheliosis, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
What conditions does Dr. Patrick G. Beatty specialize in?
While Dr. Patrick G. Beatty is a Hematology Oncology, they have specific expertise in Reticuloendotheliosis, Hairy Cell Leukemia (HCL), and Non-Hodgkin Lymphoma. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Hematology Oncology.
Does Dr. Patrick G. Beatty participate in research or clinical trials?
Yes. Dr. Patrick G. Beatty has published 5 articles and abstracts on conditions like Reticuloendotheliosis. You can view a list of Dr. Patrick G. Beatty's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Does Dr. Patrick G. Beatty accept my insurance?
Dr. Patrick G. Beatty accepts most major insurance plans, including Blue Cross Blue Shield and Medicaid. We recommend calling the office directly at 406-728-2539 to verify that your specific plan is currently accepted before your visit.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Advanced
- Hairy Cell Leukemia (HCL)Dr. Beatty isAdvanced. Learn about Hairy Cell Leukemia (HCL).
- ReticuloendotheliosisDr. Beatty isAdvanced. Learn about Reticuloendotheliosis.
- Experienced
- Acute Mountain SicknessDr. Beatty isExperienced. Learn about Acute Mountain Sickness.
- Acute Myeloblastic Leukemia with Maturation
- Acute Myeloblastic Leukemia without Maturation
- Acute Myeloid Leukemia (AML)Dr. Beatty isExperienced. Learn about Acute Myeloid Leukemia (AML).
- Acute Myelomonocytic LeukemiaDr. Beatty isExperienced. Learn about Acute Myelomonocytic Leukemia.
- Adult Soft Tissue SarcomaDr. Beatty isExperienced. Learn about Adult Soft Tissue Sarcoma.